CCL chemokines and asthma

Immunology Today

Volumn 21, Issue 5, 2000, Pages 235-242

  Teran, Luis M ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENTARY DNA; CYTOKINE; EOTAXIN; LIPID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; OXYGEN RADICAL; PROTEINASE; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHILIA; GENE EXPRESSION; GUINEA PIG; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLAMMATION; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; VIRUS INFECTION;

EID: 0034065701     PISSN: 01675699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5699(00)01634-0     Document Type: Review

References (45)

1. Lancet. 351:1998;1225-1232.
2. Teran L.M.et al. Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. Am. J. Respir. Crit. Care Med. 154:1996;469-476.
3. Montefort S.et al. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93:1994;1411-1421.
4. Frew A.J.et al. Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways. J. Allergy Clin. Immunol. 98:1996;133-143.
5. Kameyoshi Y.et al. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:1992;587-592.
6. Gonzalo J.A.et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J. Exp. Med. 188:1998;157-167.
7. Teran L.M.et al. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J. Immunol. 157:1996;1806-1812.
8. Ying S.et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4, and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and non-atopic (intrinsic asthmatics). J. Immunol. 163:1999;6321-6329.
9. Holgate S.T.et al. Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am. J. Respir. Crit. Care Med. 156:1997;1377-1383.
10. Teran L.M. Cultured nasal polyps from non-atopic and atopic patients release RANTES spontaneously and after stimulation with phytohemagglutinin. J. Allergy Clin. Immunol. 100:1997;499-504.
11. Jahnsen L.F.et al. Glucocorticosteroids inhibit mRNA expression for eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophils. J. Immunol. 163:1999;1545-1551.
12. van Damme J.et al. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to chemokine family. J. Exp. Med. 176:1992;59-65.
13. Stafford S.et al. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J. Immunol. 158:1997;4953-4960.
14. Garcia Zepeda E.A.et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:1996;5613-5626.
15. Uguccioni M.et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:1996;2379-2384.
16. Berkhout T.A.et al. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272:1997;16404-16413.
17. Jia G.Q.et al. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation. J. Exp. Med. 184:1996;1939-1951.
18. Jose P.J.et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:1994;881-887.
19. Ponath P.D.et al. Cloning of the human eosinophil chemoattractant, eotaxin expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:1996;604-612.
20. Palfram R.T.et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin-5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. Blood. 91:1998;2240-2248.
21. Teixeira M.M.et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100:1997;1657-1666.
22. Lamkhioued B.et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:1997;4593-4601.
23. Brown J.R.et al. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin. Exp. Immunol. 114:1998;137-146.
24. Nakamura H.et al. Eotaxin and impaired lung function in asthma. Am. J. Respir. Crit. Care Med. 160:1999;1952-1956.
25. Teran L.M.et al. Interleukin-5 release into asthmatic airways 4 and 24 hours after endobronchial allergen challenge: its relationship with eosinophil recruitment. Cytokine. 11:1999;518-522.
26. Patel V.P.et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Exp. Med. 185:1997;1163-1172.
27. White J.R.et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Exp. Med. 5:1997;2171-2176.
28. Forssmann U.et al. Eotaxin-2 a novel CC chemokine that is selective for the chemokine receptor CCR3 and acts like eotaxin in human eosinophil and basophil leukocytes. J. Exp. Med. 185:1997;2171-2176.
29. Ying S.et al. C-C-chemokines in allergen-induced late phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and eotaxin-2 and monocyte chemoattractant protein-4 with later 24-hour tissue eosinophilia, and relationship to basophils and other C-C- chemokines (monocyte chemoattractant protein-3 and RANTES). J. Immunol. 153:1999;3976-3984.
30. Shinkai A.et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4 stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. 163:1999;1602-1610.
31. Kitamura M.et al. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol. Chem. 274:1999;27975-27980.
32. Bochner B.S.et al. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor-3 and CC chemokine receptor 4-independent manner. Br. J. Allergy Clin. Immunol. 103:1999;527-532.
33. Gonzalo J.A.et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163:1999;403-411.
34. Youn B.et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Immunol. 159:1997;5201-5205.
35. Teran L.M.et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus induced asthma. Am. J. Respir. Crit. Care Med. 155:1997;1362-1366.
36. Teran L.M.et al. RANTES, macrophage-inhibitory protein 1 alpha, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J. Infect. Dis. 179:1999;677-681.
37. Greiff L.et al. Experimental common cold increases mucosal output of eotaxin in atopic individuals. Allergy. 54:1999;1204-1208.
38. Daugherty B.L.et al. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183:1996;2349-2354.
39. Heath H.et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:1997;178-184.
40. Mochizuki M.et al. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:1998;60-68.
41. Teran L.M.et al. Th1- and Th2 type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 20:1999;777-786.
42. Roebuck K.A.et al. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J. Leukocyte Biol. 65:1999;291-298.
43. Matsukura S.et al. Activation of eotaxin gene transcription by NF-kappaB and STAT-6 in human airway epithelial cells. J. Immunol. 163:1999;6876-6883.
44. Elsner J.et al. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur. J. Immunol. 27:1997;2892-2898.
45. Nibbs R.J.et al. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J. Immunol. 164:2000;1488-1497.